Current Position, Affiliation
- Professor, University of Leicester & The John Walls Renal Unit, Leicester, UK
Education / Training
- 1992, M.D., University of Manchester, UK
- 2000, PhD., University of Leicester
Professional and Research Experience
- 2007 - Present, Professor, University of Leicester
Selected Publications
- Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy. N Engl J Med. 2024 Oct 25. doi: 10.1056/NEJMoa2410316. PMID: 39453772
- Atrasentan in Patients with IgA Nephropathy. N Engl J Med. 2024 Oct 25. doi: 10.1056/NEJMoa2409415. PMID: 39460694
- Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort. Lancet. 2024 Mar 13:S0140-6736(23)02843-X. doi: 10.1016/S0140-6736(23)02843-X. PMID: 38492578
- Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial. Lancet. 2023 Nov 2:S0140-6736(23)02302-4. doi: 10.1016/S0140-6736(23)02302-4. PMID: 37931634
- Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial. Lancet. 2023 Sep 9;402(10405):859-870. doi: 10.1016/S0140-6736(23)01554-4. Epub 2023 Aug 14. PMID: 37591292
Plenary Lecture 2
Role
Speaker
Date & Time
12/05 15:10 - 16:00
Place
Room 1 ( 701A )
Lecture Title
The Rapidly Evolving Treatment Paradigm for IgA Nephropathy
IgA Nephropathy
Role
Speaker
Date & Time
12/06 11:55 - 12:10
Place
Room 4 ( 701EF )
Lecture Title
Future Clinical Trials in IgA Nephropathy
Meet the Professors
Role
Speaker
Date & Time
12/07 10:55 - 12:25
Place
Room 4 ( 701EF )
Lecture Title
Meet the Professors